Objectives: To examine the role of complement in the development of ac
id aspiration-induced lung injury in the rat. It was postulated that i
nhibition or depletion of complement attenuates aspiration-induced lun
g injury. Design: Controlled animal trial. Setting: Animal Laboratory,
Jefferson Medical College, Philadelphia, PA. Subjects: Anesthetized r
ats. Interventions: Aspiration was induced by the intratracheal admini
stration of 0.2 mL of 0.1 N hydrochloric acid (n = 7) and lung injury
was evaluated by determining water content, myeloperoxidase activity,
protein concentration, and leukocyte count in bronchoalveolar lavage f
luid, Muscle Po-2 was directly measured using a thin-film chamber oxyg
en sensor and serum tumor necrosis factor-a was assayed by enzyme-link
ed immunosorbent assay. The effect of complement inhibition by recombi
nant human soluble complement receptor type 1 (n = 8) or complement de
pletion by cobra venom factor (n = 7) on lung injury was evaluated. Me
asurements and Main Results: Acid aspiration induced pulmonary leukose
questration, edema, and a microvascular permeability defect, along wit
h tissue hypoxia. Pretreatment with soluble complement receptor type 1
(complement inhibition) or cobra venom factor (complement depletion)
significantly reduced lung edema (-61 +/- 7%; p < .05), eliminated pro
tein accumulation in bronchoalveolar lavage fluid (p < .01), and impro
ved (p < .05) tissue oxygenation. In contrast, there was no effect of
soluble complement receptor type 1 or of cobra venom factor on leukose
questration. Conclusions: Acid aspiration induces lung injury through
a complement-dependent mechanism that leads to microvascular permeabil
ity defects. Therefore, the possibility that complement inhibitors may
have a salutary effect in humans with aspiration-induced lung injury
should be investigated.